# Meticuly Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/meticuly-co

- Industry: Software
- Headquarters: Bangkok, Thailand
- Website: www.meticuly.com
- Total disclosed funding: $2.7M
- Latest round: Series A (Oct 8, 2019)
- Investors on record: 1

## About

Meticuly Co., Ltd. specializes in creating patient-specific implants leveraging advanced 3D printing technology, enhancing surgical outcomes with tailored solutions for various medical conditions.Founded in 2017 in Bangkok, Thailand, Meticuly Co., Ltd. designs and manufactures bespoke medical implants. The company was established by Chedtha Puncreobutr and has successfully executed 4 deals to date. Their most recent funding round was a Series B, raising USD 4.2 mn on January 26, 2022, led by BE Healthcare Ventures. They have not pivoted their business strategy significantly since inception and currently have no reported subsidiaries.Meticuly specializes in the design and manufacturing of high-quality patient-specific implants using advanced 3D printing technology. Their core product offerings include customized solutions for cranioplasty, mandible reconstruction, mid-face reconstruction, and oculoplastic reconstruction. These implants are tailored to the unique anatomical needs of each patient, ensuring a more precise fit and improved surgical outcomes. Meticuly's technology integrates AI-driven algorithms with advanced materials, enabling surgeons to provide personalized care addressing specific medical conditions. They serve over 850 surgeons and more than 240 hospitals globally, targeting markets across North America, Europe, and Asia.In 2022, Meticuly generated revenue of USD 437,100.30, with an EBITDA of USD -1,685,158.40. The company engages in direct business-to-business transactions, supplying bespoke medical implants based on contracts that detail specific patient requirements. Their process streamlines design to delivery, allowing timely surgical interventions while pricing details remain proprietary.Following their Series B funding of USD 4.2 mn led by BE Healthcare Ventures in January 2022, Meticuly plans to enhance its product offerings and enter new markets. Upcoming products include innovative designs for additional medical applications, though specific release dates have not been disclosed. The company aims to expand its presence in North America and Europe by mid-2023, utilizing funding to support these initiatives and further the development of their advanced implant technology.

## Funding rounds

- Series A, Oct 8, 2019, $2.7M — Expara

## Investors

- Expara (https://capitalatlas.ai/funds/expara) — Series A